|
LOC642852 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.19091453049714E-13 |
| Normal-vs-Stage3 |
1.62436730732907E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.576000E-02 |
| Stage1-vs-Stage3 |
1.873250E-01 |
| Stage1-vs-Stage4 |
6.464200E-02 |
| Stage2-vs-Stage3 |
4.620100E-03 |
| Stage2-vs-Stage4 |
2.075500E-03 |
| Stage3-vs-Stage4 |
4.000400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.42070000208605E-08 |
| Normal-vs-Asian |
1.62436730732907E-12 |
| Caucasian-vs-AfricanAmerican |
7.674500E-02 |
| Caucasian-vs-Asian |
6.132400E-01 |
| AfricanAmerican-vs-Asian |
1.175560E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
9.971400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
2.84289999996634E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.524600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.545980E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.552800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.870400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.786000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.853600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.4265000003455E-07 |
| Classical-VS-Follicular |
1.563540E-03 |
| Classical-VS-Other |
9.637000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.6595003976837E-10 |
| Tall-VS-Other |
1.043550E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.908600E-01 |
| Follicular-VS-Normal |
1.62525548574877E-12 |
| Other-VS-Normal |
1.7569899999903E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.209710E-02 |
|
|
